Medicines Co (NASDAQ:MDCO)

Tuesday’s trading has closed, but MDCO is being traded in the after-hours session. After-Hours quote »
33.48
Delayed Data
As of 3:59pm ET
 +0.09 / +0.27%
Today’s Change
19.92
Today|||52-Week Range
34.70
+21.00%
Year-to-Date
Will Amgen (AMGN) Keep the Earnings Streak Alive in 2Q? - Analyst Blog
5:09pm / Zacks.com
Will AbbVie (ABBV) Surprise on Earnings Again in Q2? - Analyst Blog
Jul 23 / Zacks.com
Will Rising Costs Hurt Alexion (ALXN) Earnings in Q2? - Analyst Blog
4:19pm / Zacks.com
Will Currency and Generics Hit Eli Lilly's Q2 Earnings? - Analyst Blog
Jul 21 / Zacks.com
Will Vertex (VRTX) Surprise with a Lower Loss in Q2? - Analyst Blog
3:29pm / Zacks.com
Can Bristol-Myers (BMY) Keep its Earnings Streak Alive? - Analyst Blog
Jul 21 / Zacks.com
What's in Store for Hospira (HSP) this Earnings Season? - Analyst Blog
Jul 27 / Zacks.com
Will Agenus (AGEN) Disappoint Investors this Earnings? - Analyst Blog
Jul 21 / Zacks.com
Will Currency & Generics Weigh on Pfizer (PFE) Q2 Earnings? - Analyst Blog
Jul 27 / Zacks.com
What's in Store for Celgene (CELG) This Earnings Season? - Analyst Blog
Jul 21 / Zacks.com
Gilead (GILD) to Report Q2 Earnings: Surprise in the Cards? - Analyst Blog
Jul 24 / Zacks.com
Will AmerisourceBergen (ABC) Disappoint Earnings in Q3? - Analyst Blog
Jul 21 / Zacks.com
Will Express Scripts (ESRX) Miss Earnings Estimates in Q2? - Analyst Blog
Jul 24 / Zacks.com
Hospira (HSP) Launches Generic Angiomax in the U.S. - Analyst Blog
Jul 17 / Zacks.com
Will Merck (MRK) Pull a Surprise this Earnings Season? - Analyst Blog
Jul 24 / Zacks.com
Will Novartis (NVS) Disappoint Q2 Earnings due to Generics? - Analyst Blog
Jul 17 / Zacks.com
Will Biogen (BIIB) Surprise in 2Q Despite Tecfidera Issues? - Analyst Blog
Jul 23 / Zacks.com
The Zacks Analyst Blog Highlights: Eli Lilly, Valeant Pharmaceuticals International, ...
Jul 15 / Zacks.com

To view my watchlist

Not a member yet?

Sign up now for a free account